发布求助
文献互助 智能选刊 最新文献

Journal of Thoracic Oncology最新文献

筛选
英文 中文
OA10.06 Impact of Brain Metastases on Safety and Efficacy of MK-6070, a DLL3-Targeting T Cell Engager, in Small Cell Lung Cancer OA10.06 脑转移对小细胞肺癌 DLL3 靶向 T 细胞激活剂 MK-6070 的安全性和有效性的影响
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.09.060
N.J. Choudhury , H. Beltran , M.L. Johnson , E.L. Schenk , R.E. Sanborn , J.R. Thompson , H. Mamdani , A. Dowlati , R.R. Aggarwal , A.W. Gramza MD , P. Jain
{"title":"OA10.06 Impact of Brain Metastases on Safety and Efficacy of MK-6070, a DLL3-Targeting T Cell Engager, in Small Cell Lung Cancer","authors":"N.J. Choudhury , H. Beltran , M.L. Johnson , E.L. Schenk , R.E. Sanborn , J.R. Thompson , H. Mamdani , A. Dowlati , R.R. Aggarwal , A.W. Gramza MD , P. Jain","doi":"10.1016/j.jtho.2024.09.060","DOIUrl":"10.1016/j.jtho.2024.09.060","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Pages S32-S33"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142441323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA11.04 Volrustomig + platinum doublet chemotherapy (CTx) in first-line non-small cell lung cancer (NSCLC): Phase 1b trial update OA11.04 Volrustomig + 铂双联化疗 (CTx) 用于一线非小细胞肺癌 (NSCLC)：1b期试验更新
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.09.062
D.R. Spigel , M.-J. Ahn , M. Majem , L. Medina Rodríguez , K.H. Lee , E. Carcereny , A.A. Hernández , A. Insa , E.K. Cho , B. Besse , S.Y. Rha , J. Weiss , M. D'Arcangelo , S.-A. Im , S.-W. Kim , B.A. Carneiro , S.M. Gadgeel , P. Mitchell , J.M. Asare , S.D. Gainer , E. Felip
{"title":"OA11.04 Volrustomig + platinum doublet chemotherapy (CTx) in first-line non-small cell lung cancer (NSCLC): Phase 1b trial update","authors":"D.R. Spigel , M.-J. Ahn , M. Majem , L. Medina Rodríguez , K.H. Lee , E. Carcereny , A.A. Hernández , A. Insa , E.K. Cho , B. Besse , S.Y. Rha , J. Weiss , M. D'Arcangelo , S.-A. Im , S.-W. Kim , B.A. Carneiro , S.M. Gadgeel , P. Mitchell , J.M. Asare , S.D. Gainer , E. Felip","doi":"10.1016/j.jtho.2024.09.062","DOIUrl":"10.1016/j.jtho.2024.09.062","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Pages S33-S34"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142441325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA15.04 Multi-Omic Profiling of Paired Non-Small Cell Lung Cancer and Draining Lymph Nodes Reveals Novel T-Cell Differentiation Patterns OA15.04 对配对的非小细胞肺癌和引流淋巴结进行多指标图谱分析，揭示新的T细胞分化模式
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.09.077
V. Gerretsen , W. de Koning , X. Li , N. Rozendaal , R. Stadhouders , M. Schuijs , B. Lambrecht , J. Aerts , F. Dammeijer
{"title":"OA15.04 Multi-Omic Profiling of Paired Non-Small Cell Lung Cancer and Draining Lymph Nodes Reveals Novel T-Cell Differentiation Patterns","authors":"V. Gerretsen , W. de Koning , X. Li , N. Rozendaal , R. Stadhouders , M. Schuijs , B. Lambrecht , J. Aerts , F. Dammeijer","doi":"10.1016/j.jtho.2024.09.077","DOIUrl":"10.1016/j.jtho.2024.09.077","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Pages S43-S44"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142441147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Response to the Letter to the Editor: Response to Ficonalkib’s Promise and the Path Forward: A Comment on Advanced ALK-Positive NSCLC Treatment 回应致编辑的信：对 Ficonalkib 的承诺和前进之路的回应：关于 ALK 阳性晚期 NSCLC 治疗的评论。
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.06.023
Yuankai Shi MD
{"title":"A Response to the Letter to the Editor: Response to Ficonalkib’s Promise and the Path Forward: A Comment on Advanced ALK-Positive NSCLC Treatment","authors":"Yuankai Shi MD","doi":"10.1016/j.jtho.2024.06.023","DOIUrl":"10.1016/j.jtho.2024.06.023","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Page e48"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on “Passive Smoking-Induced Mutagenesis as a Promoter of Lung Carcinogenesis” 关于 "被动吸烟诱发的突变是肺癌发生的促进因素 "的评论。
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.06.021
Xian Gu MD, Zhiyuan Han MD, Wenbo Shi MD
{"title":"Comment on “Passive Smoking-Induced Mutagenesis as a Promoter of Lung Carcinogenesis”","authors":"Xian Gu MD, Zhiyuan Han MD, Wenbo Shi MD","doi":"10.1016/j.jtho.2024.06.021","DOIUrl":"10.1016/j.jtho.2024.06.021","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Pages e51-e52"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA01.05 Neoadjuvant Nivolumab with or without Relatlimab in Resectable NSCLC: Additional Analysis and Extended Follow-up OA01.05 新辅助 Nivolumab 联合或不联合 Relatlimab 治疗可切除的 NSCLC：补充分析和延长随访
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.09.024
K. Cuppens , P. Baas , M. Wiesweg , B. Du Pont , T. Ploenes , D. Theegarten , C. Aigner , K. Hartemink , B. Maes , K. Pat , M. Schuler
{"title":"OA01.05 Neoadjuvant Nivolumab with or without Relatlimab in Resectable NSCLC: Additional Analysis and Extended Follow-up","authors":"K. Cuppens , P. Baas , M. Wiesweg , B. Du Pont , T. Ploenes , D. Theegarten , C. Aigner , K. Hartemink , B. Maes , K. Pat , M. Schuler","doi":"10.1016/j.jtho.2024.09.024","DOIUrl":"10.1016/j.jtho.2024.09.024","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Page S9"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142441472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MA01.13 Adherence to Treatment Protocol of Patients Submitted to Neoadjuvant (Chemo) Immunotherapy in Resectable NSCLC: Ameta Analysis MA01.13 接受新辅助（化疗）免疫疗法的可切除 NSCLC 患者对治疗方案的依从性：艾美塔分析
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.09.099
F. Guerrera , F.T. Gallina , E. Balzani , D. Marinelli , A. Nuccio , R. Ferrara , A. Di Federico , F. Ambrosi , E. Faccioli , M. Mammana , A. Ferro , M. Sepulcri , R. Giusti , A. Pittaro , G. Viscardi , P. Bertoglio
{"title":"MA01.13 Adherence to Treatment Protocol of Patients Submitted to Neoadjuvant (Chemo) Immunotherapy in Resectable NSCLC: Ameta Analysis","authors":"F. Guerrera , F.T. Gallina , E. Balzani , D. Marinelli , A. Nuccio , R. Ferrara , A. Di Federico , F. Ambrosi , E. Faccioli , M. Mammana , A. Ferro , M. Sepulcri , R. Giusti , A. Pittaro , G. Viscardi , P. Bertoglio","doi":"10.1016/j.jtho.2024.09.099","DOIUrl":"10.1016/j.jtho.2024.09.099","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Pages S56-S57"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142440934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Title Page 标题页
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/S1556-0864(24)02285-8
{"title":"Title Page","authors":"","doi":"10.1016/S1556-0864(24)02285-8","DOIUrl":"10.1016/S1556-0864(24)02285-8","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Page A2"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142440975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PL02.04 Phase 3 Study of Ivonescimab (AK112) vs. Pembrolizumab as First-line Treatment for PD-L1-positive Advanced NSCLC: Primary Analysis of HARMONi-2 PL02.04 Ivonescimab (AK112) 与 Pembrolizumab 作为 PD-L1 阳性晚期 NSCLC 一线治疗的 3 期研究：HARMONi-2 的初步分析
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.09.012
C. Zhou , J. Chen , L. Wu , L. Wang , B. Liu , J. Yao , H. Zhong , J. Li , Y. Cheng , Y. Sun , H. Ge , Q. Shi , M. Zhou , Z. Han , J. Wang , Q. Bu , Y. Zhao , J. Chen , J. Yang , M. Xia
{"title":"PL02.04 Phase 3 Study of Ivonescimab (AK112) vs. Pembrolizumab as First-line Treatment for PD-L1-positive Advanced NSCLC: Primary Analysis of HARMONi-2","authors":"C. Zhou , J. Chen , L. Wu , L. Wang , B. Liu , J. Yao , H. Zhong , J. Li , Y. Cheng , Y. Sun , H. Ge , Q. Shi , M. Zhou , Z. Han , J. Wang , Q. Bu , Y. Zhao , J. Chen , J. Yang , M. Xia","doi":"10.1016/j.jtho.2024.09.012","DOIUrl":"10.1016/j.jtho.2024.09.012","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Page S1"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142440976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA15.03 Clinicogenomic Landscape of Lymph Node Metastases in TRACERx OA15.03 TRACERx 淋巴结转移的临床基因组学特征
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.09.076
T. Karasaki , M. Al Bakir , A. Huebner , J.R.M. Black , C. Abbosh , N. McGranahan , A.M. Frankell , M. Jamal-Hanjani , C. Swanton
{"title":"OA15.03 Clinicogenomic Landscape of Lymph Node Metastases in TRACERx","authors":"T. Karasaki , M. Al Bakir , A. Huebner , J.R.M. Black , C. Abbosh , N. McGranahan , A.M. Frankell , M. Jamal-Hanjani , C. Swanton","doi":"10.1016/j.jtho.2024.09.076","DOIUrl":"10.1016/j.jtho.2024.09.076","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Page S43"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142441146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信